Spots Global Cancer Trial Database for oligometastases
Every month we try and update this database with for oligometastases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer | NCT02192788 | Oligometastatic... | Stereotactic Bo... | 18 Years - | Grupo de Investigación Clínica en Oncología Radioterapia | |
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging | NCT06276465 | Prostatic Cance... | Darolutamide 30... Stereotactic bo... Androgen depriv... | 18 Years - | UNICANCER | |
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC | NCT05277844 | Oligometastatic... Non-small Cell ... Driver Mutation | Local Consolida... TKI | 18 Years - 99 Years | Tata Memorial Hospital | |
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | NCT04610372 | Oligometastatic... | Hypofractionate... High dose rate ... Permanent seed ... Stereotactic bo... | 18 Years - | British Columbia Cancer Agency | |
Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases | NCT02759783 | Prostate Cancer Breast Cancer Carcinoma, Non-... | SBRT Standard of Car... | 18 Years - | Royal Marsden NHS Foundation Trust | |
SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue Metastases | NCT04407897 | Solid Tumor Oligometastases Soft Tissue Dis... | Stereotactic ra... | 18 Years - 99 Years | Herlev Hospital | |
Radiotherapy for Extracranial Oligometastatic Breast Cancer | NCT04646564 | Breast Cancer M... | standard of car... radiotherapy + ... | 18 Years - 70 Years | ChineseAMS | |
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases | NCT03427541 | Non Small Cell ... | Surgeries | - | Tang-Du Hospital | |
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | NCT04075305 | Oncology Breast Cancer Prostate Cancer Gynecologic Can... Brain Tumor Brain Cancer Gynecologic Tum... Prostate Tumor Prostate Neopla... Breast Tumor Radiation Toxic... Quality of Life Rectal Cancer Rectal Tumor Rectal Neoplasm... Lung Cancer Lung Tumor Lung Neoplasm Esophageal Canc... Esophagus Cance... Esophageal Tumo... Esophageal Neop... Esophagus Tumor Esophagus Neopl... Pancreatic Canc... Pancreatic Tumo... Pancreatic Neop... Head and Neck C... Head and Neck N... Head and Neck T... Tumor Neoplasms Bladder Cancer Bladder Neoplas... Liver Cancer Liver Neoplasms Liver Metastase... Oligometastases | Radiation thera... | 18 Years - | UMC Utrecht | |
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor. | NCT06120426 | Spinal Metastas... Spinal Tumor Radiotherapy Malignant Bone ... Surgery | total en bloc s... | 18 Years - 75 Years | Shanghai Changzheng Hospital | |
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases | NCT03427541 | Non Small Cell ... | Surgeries | - | Tang-Du Hospital | |
Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location | NCT04925583 | Lung Cancer | Stereotactic bo... | 18 Years - | University Hospital Heidelberg | |
5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases | NCT01761929 | Solid Tumors Wi... | Radiation: 50Gy... | 18 Years - | University Health Network, Toronto | |
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC | NCT05277844 | Oligometastatic... Non-small Cell ... Driver Mutation | Local Consolida... TKI | 18 Years - 99 Years | Tata Memorial Hospital | |
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer | NCT04443062 | Prostate Cancer | 177Lu-PSMA-617 | 18 Years - | Radboud University Medical Center | |
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor. | NCT06120426 | Spinal Metastas... Spinal Tumor Radiotherapy Malignant Bone ... Surgery | total en bloc s... | 18 Years - 75 Years | Shanghai Changzheng Hospital | |
Definitive Therapy for Oligometastatic Solid Malignancies | NCT01898962 | Stage IV or Rec... | Complete Surgic... Stereotactic Ra... Ablative extern... Subtotal surgic... Radioembolizati... | 18 Years - | Rocky Mountain Cancer Centers | |
5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases | NCT01761929 | Solid Tumors Wi... | Radiation: 50Gy... | 18 Years - | University Health Network, Toronto | |
Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging | NCT04086082 | Lung Cancer | Markerless Imag... | 18 Years - | University of Sydney | |
Definitive Therapy for Oligometastatic Solid Malignancies | NCT01898962 | Stage IV or Rec... | Complete Surgic... Stereotactic Ra... Ablative extern... Subtotal surgic... Radioembolizati... | 18 Years - | Rocky Mountain Cancer Centers |